Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO 2024 | Applying real-world treatment patterns in prostate cancer in Greece

Aristotelis Bamias • 13 Sep 2024
ESMO 2024
Genitourinary Cancer Prostate Cancer

Aristotelis Bamias, MD, PhD, University of Athens, Athens, Greece, comments on the importance of translational medicine, especially in prostate cancer. Whilst there have been many advances in clinical trials, Prof. Bamias highlights the need for them to be applicable in the clinical practice. In Greece, patients additionally need to be able to receive the latest standard of care, so that outcomes can be comparable to that of other countries. This interview took place at the European Society for Medical Oncology (ESMO) 2024 Congress in Barcelona, Spain.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Aristotelis Bamias

What to look forward to in GU cancers at ESMO 2024
1:52
What to look forward to in GU cancers at ESMO 2024
Aristotelis Bamias • 13 Sep 2024
Evaluating futibatinib, EV and DV with pembrolizumab in urothelial carcinoma
3:43
Evaluating futibatinib, EV and DV with pembrolizumab in urothelial carcinoma
Aristotelis Bamias • 13 Sep 2024
IMvigor130: clinical implications and next steps
2:06
IMvigor130: clinical implications and next steps
Aristotelis Bamias • 18 Feb 2023
ASCO GU 2023: moving immunotherapy into the first-line setting for bladder cancer
1:12
ASCO GU 2023: moving immunotherapy into the first-line setting for bladder cancer
Aristotelis Bamias • 18 Feb 2023

Related Videos

Current and emerging systemic strategies in biochemically relapsed prostate cancer
2:45
Current and emerging systemic strategies in biochemically relapsed prostate cancer
Ashwin Sachdeva • 16 May 2026
How has SABR improved radiotherapy practice in kidney cancer?
1:06
How has SABR improved radiotherapy practice in kidney cancer?
Shankar Siva • 16 May 2026
Which patients with kidney cancer may benefit from SABR treatment?
1:58
Which patients with kidney cancer may benefit from SABR treatment?
Shankar Siva • 16 May 2026
Management of brain metastasis in patients with poor-risk testicular cancer
1:03
Management of brain metastasis in patients with poor-risk testicular cancer
Darren Feldman • 30 May 2026
The content of VJOncology is intended for healthcare professionals